Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The Environmental Protection Agency is proposed banning a cancer-causing chemical that can be found in products like car break cleaners, laundry spot removers and some arts and crafts sprays.
The Centers for Disease Control and Prevention issued a warning to doctors, saying a key drug used to prevent respiratory infections in babies is in limited supply.
